Results 31 to 40 of about 615,781 (294)
Journal of Diabetes Investigation, 2021 To examine the performance and identify the optimal threshold of vibration perception threshold (VPT) for diagnosing diabetic polyneuropathy (DPN) in a Chinese population according to multiple definitions of DPN as gold standards.
Min Liu +6 more
semanticscholar +1 more source
Molecular underpinnings of diabetic polyneuropathy [PDF]
Journal of Applied Physiology, 2016 to the editor: Allen and colleagues ([2][1]) provided an in-depth review of the pathophysiology and functional outcomes of diabetic polyneuropathy (DPN) among patients with diabetes mellitus (DM).
Senefeld, Jonathon, Hunter, Sandra K.
openaire +3 more sources
Ranirestat for the Management of Diabetic Sensorimotor Polyneuropathy [PDF]
Diabetes Care, 2009 OBJECTIVE Aldose reductase inhibitors (ARIs) are potential disease modifiers for diabetes complications. We aimed to determine whether ranirestat, an ARI, could slow or reverse the course of diabetic sensorimotor polyneuropathy (DSP). RESEARCH DESIGN AND METHODS
Vera Bril +3 more
openalex +5 more sources
Internal Medicine, 2020 Objective To achieve an accurate quantification in diabetic polyneuropathy (DPN), we developed a new electrophysiological index that we called the DPN index. The relationship between the DPN index and the neurological findings in diabetic patients was assessed.
Keiichi Yokoi +8 more
openaire +4 more sources
Treatment of Diabetic Sensory Polyneuropathy [PDF]
Current Treatment Options in Neurology, 2011 No current disease-modifying treatments have been shown definitively in randomized clinical trials to reduce or reverse diabetic sensory polyneuropathy (DSP). It is increasingly recognized that individuals with "prediabetes" or impaired glucose regulation can already have a "small-fiber" neuropathy, or mild DSP, in which sensory axons of both small and
James W. Russell, Lindsay A. Zilliox
openaire +3 more sources
Association Between Overactive Bladder and Polyneuropathy in Diabetic Patients [PDF]
International Neurourology Journal, 2016 Purpose Diabetes mellitus (DM) is a chronic metabolic disorder that often leads to complications. We aimed to correlate two complications of DM, polyneuropathy and hyperactive bladder syndrome, using noninvasive measures, such as screening tests. Methods
Nermin Tanik +8 more
doaj +1 more source
Pathogenesis of Distal Symmetrical Polyneuropathy in Diabetes
Life, 2022 Distal symmetrical polyneuropathy (DSPN) is a serious complication of diabetes associated with significant disability and mortality. Although more than 50% of people with diabetes develop DSPN, its pathogenesis is still relatively unknown. This lack of understanding has limited the development of novel disease-modifying therapies and left the reasons ...
Smith, Sasha +5 more
openaire +6 more sources
European Journal of Neurology, 2020 Diabetic polyneuropathy (DPN) is a common complication of diabetes. Using the Toronto criteria for diabetic polyneuropathy and the grading system for neuropathic pain, the performance of neuropathy scales and questionnaires were assessed by comparing ...
S. S. Gylfadottir +20 more
semanticscholar +1 more source
Медицинский совет, 2016 α-Lipoic acid (thioctic) (ALA) is the most applicable pharmacological drug for treatment of diabetic polyneuropathy. The articles explores the results of experimental studies on α-Lipoic acid effect upon formation mechanisms of peripheral nerves ...
I. A. Strokov, A. S. Phokina
doaj +1 more source
Differential diagnosis of polyneuropathies in diabetes mellitus
Медицинский совет, 2021 Diabetic polyneuropathy (DPN) is heterogeneous in its clinical course and clinical manifestations. Depending on the primary lesion of large or small nerve fibers, different onset, course and clinical manifestations of polyneuropathy are possible.
V. N. Khramilin
doaj +1 more source